Tirzepatide, provider-led.
A once-weekly medication that acts on two appetite-related hormone receptors, dosed and adjusted by your provider.

- TypeCompounded (not FDA-approved) · Dual GIP / GLP-1 receptor agonist
- FormsWeekly injection
- Supply3-month supply
- ShippingCold-chain, discreet packaging
About Tirzepatide.
Tirzepatide activates two receptors, GIP and GLP-1, involved in appetite and blood sugar regulation.
ZIND's version is prepared and dispensed by The Pharmacy Hub, a licensed 503A pharmacy. Compounded medications are not FDA-approved.
In plain language.
By acting on both GIP and GLP-1 pathways, tirzepatide helps signal fullness and slows stomach emptying.
Like other GLP-1 treatments, it starts at a low dose and is stepped up gradually under your provider's guidance.
It may suit you if…
Your provider makes the final call after reviewing your health history.
- 01Adults looking for medical support with weight management
- 02People comfortable with a once-weekly self-injection
- 03Anyone who wants to discuss a dual-action option with a provider
From profile to ongoing care.
- 1Build your profile
Answer a few questions about your goals and health history. It's free and takes about two minutes.
- 2Provider review
A licensed provider reviews your profile and decides whether this medication is appropriate for you.
- 3Your first weeks
You begin on a low weekly dose. Stomach side effects are most common when starting or increasing a dose.
- 4Check-ins and adjustments
Message your care team about how you feel. Your provider adjusts your plan as you go.
Tirzepatide pricing.
Every product and price, as you'll see them at checkout. You're only charged if your provider prescribes.
Compounded tirzepatide
Weekly injection
| Product | Price |
|---|---|
| Tirzepatide injectable, 3-month supply Compounded | $749 every 3 months |
Compounded medications are not FDA-approved. The FDA does not verify their safety, effectiveness or quality.
Weight Loss options.
Tirzepatide questions, answered.
Still unsure? Build your profile and ask your provider. It's free.
Semaglutide acts on GLP-1 receptors; tirzepatide acts on both GIP and GLP-1 receptors. Your provider will help you decide which is appropriate.
No. Compounded tirzepatide is prepared and dispensed by The Pharmacy Hub, a licensed 503A pharmacy, for an individual patient, and isn't FDA-approved. The FDA does not verify the safety, effectiveness or quality of compounded drugs.
Sometimes. Your provider reviews your history and current dose before recommending a switch.

See if Tirzepatide is right for you.
Two minutes to build your profile. A licensed provider takes it from there.
Get started